Quantitative levels of serum N-glycans in type 1 diabetes and their association with kidney disease

Marco Colombo, Akram Asadi Shehni, Ioanna Thoma, Stuart J. McGurnaghan, Luke A.K. Blackbourn, Hayden Wilkinson, Andrew Collier, Alan W. Patrick, John R. Petrie, Paul M. McKeigue, Radka Saldova, Helen M. Colhoun*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

We investigated associations of quantitative levels of N-glycans with hemoglobin A1c (HbA1c), renal function and renal function decline in type 1 diabetes. We measured 46 total N-glycan peaks (GPs) on 1565 serum samples from the Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO) and a pool of healthy donors. Quantitation of absolute abundance of each GP used 2AB-labeled mannose-3 as a standard. We studied cross-sectional associations of GPs and derived measures with HbA1c, albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR), and prospective associations with incident albuminuria and final eGFR. All GPs were 1.4 to 3.2 times more abundant in SDRTN1BIO than in the healthy samples. Absolute levels of all GPs were slightly higher with higher HbA1c, with strongest associations for triantennary trigalactosylated disialylated, triantennary trigalactosylated trisialylated structures with core or outer arm fucose, and tetraantennary tetragalactosylated trisialylated glycans. Most GPs showed increased abundance with worsening ACR. Lower eGFR was associated with higher absolute GP levels, most significantly with biantennary digalactosylated disialylated glycans with and without bisect, triantennary trigalactosylated trisialylated glycans with and without outer arm fucose, and core fucosylated biantennary monogalactosylated monosialylated glycans. Although several GPs were inversely associated prospectively with final eGFR, cross-validated multivariable models did not improve prediction beyond clinical covariates. Elevated HbA1c is associated with an altered N-glycan profile in type 1 diabetes. Although we could not establish GPs to be prognostic of future renal function decline independently of HbA1c, further studies to evaluate their impact in the pathogenesis of diabetic kidney disease are warranted.
Original languageEnglish
Pages (from-to)613-623
Number of pages11
JournalGlycobiology
Volume31
Issue number5
Early online date27 Nov 2020
DOIs
Publication statusPublished - May 2021

Keywords

  • Diabetic kidney disease
  • Glycemia control
  • N-glycans
  • Type 1 diabetes
  • UPLC

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Quantitative levels of serum N-glycans in type 1 diabetes and their association with kidney disease'. Together they form a unique fingerprint.

Cite this